𝔖 Bobbio Scriptorium

✦ LIBER ✦

Single-Pill Combination of Telmisartan/Amlodipine Versus Amlodipine Monotherapy in Diabetic Hypertensive Patients: An 8-Week Randomized, Parallel-Group, Double-Blind Trial

✍ Scribed by Arya M. Sharma; George Bakris; Joel M. Neutel; Thomas W. Littlejohn; Maureen Kobe; Naitee Ting; Ludwin Ley

Book ID: 113544600
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 768 KB
Volume: 34
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2012.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An 18-week, prospective, randomized, dou

An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: The assessment of combination therapy of amlodipine/ramipril (ATAR) study

✍ Roberto Dischinger Miranda; Décio Mion Jr; Joăo Carlos Rocha; Oswaldo Kohlmann J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 797 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up noninferiority trial

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Comparative Efficacy and Safety Profile

Comparative Efficacy and Safety Profile of Amlodipine 5 mg/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study

✍ Seok-Min Kang; Jong-Chan Youn; Shung Chull Chae; Chang Gyu Park; Joo Young Yang; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Results of a comparative, phase III, 12-

Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension

✍ Akhilesh Sharma; Ananda Bagchi; Satish B. Kinagi; Yogesh Kumar Sharma; Vidyagaur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Evaluation of the Efficacy and Tolerabil

Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

✍ Hiromi Rakugi; Toshio Ogihara; Yuko Miyata; Kiyofumi Sasai; Nobuo Totsuka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 318 KB